Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Jeffrey Alan Sosman
Based on 112 articles published since 2008
||||
Expertise Level
The expertise of Jeffrey Alan Sosman ranks in the
  • Top 0.023%
  • ... of 102,031 published authors worldwide on Melanoma
  • ... from 2008 through 2018
  • ... based on contributions to 112 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Sosman, Jeffrey A   ·   Sosman, J A   ·   Sosman, Jeffrey Alan   ·   Sosman, J   ·   Sosman, Jeff   ·   Sosman, Jeffery A   ·   Sosman, Jeffrey
Work Locations
Details
Most likely:    Vanderbilt University   Contact    
2018
  • University of California Los Angeles, Los Angeles, California, USA. · Moffitt Cancer Center and University of South Florida, Tampa, Florida, USA. · The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA. · University of California San Francisco, San Francisco, California, USA. · Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Weill Cornell Medical College, New York, New York, USA. · Georgetown Lombardi Cancer Center, Washington DC, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, California, USA. · Mayo Clinic, Jacksonville, Florida, USA. · The University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Pubmed 29320474
2017
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Center for Cancer Precision Medicine/Dana-Farber Cancer Institute and the Broad Institute, Boston, Massachusetts. · Broad Institute of MIT and Harvard, Cambridge, Massachusetts. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. · Dana Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · California Pacific Medical Center Research Institute, San Francisco, California. · Vanderbilt-Ingram Cancer Center, Vanderbilt, Tennessee. · University Hospital, Zurich, Switzerland. · Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Novartis Pharma AG, Basel, Switzerland. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia. · Pubmed 28719152
  • Sanjiv S. Agarwala, Saint Luke's University Hospital, Easton · Uma N. Rao, Ahmad A. Tarhini, Terry L. Evans, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Sandra J. Lee, and Waiki Yip, Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA · Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD · Douglas S. Reintgen, Lakeland Regional Cancer Center, Lakeland · Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL · Joanna M. Brell, MetroHealth Medical Center, Cleveland · William E. Carson, The Ohio State University Comprehensive Cancer Center, Columbus, OH · Mark R. Albertini, University of Wisconsin Hospital, Madison, WI · Michael B. Atkins, Georgetown Medical Center, Washington, DC · Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS · Robert M. Conry, University of Alabama at Birmingham, Birmingham, AL · Jeffrey A. Sosman, Vanderbilt University, Nashville · Alberto S. Pappo, Saint Jude Children's Research Hospital Oncology, Memphis, TN · Lawrence E. Flaherty, Wayne State University/Karmanos Cancer Institute, Detroit, MI · Michael G. Smylie, Cross Cancer Institute, Edmonton, Canada · and Richard F. Kefford, Sydney West Area Health Service, Westmead, Australia. · Pubmed 28135150
  • Department of Oncology, Mayo Clinic, 200 First St, SW, Rochester, MN, 55905, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Yale University, New Haven, CT, USA. · University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · New York University Langone Medical Center, New York, NY, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · AstraZeneca Pharmaceuticals, Waltham, MA, USA. · Present address: Array BioPharma Inc., Boulder, CO, USA. · Pubmed 27650277
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · David Geffen School of Medicine, University of California, Los Angeles, California. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, California. · Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, California. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Pubmed 28864476
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · James Larkin, Royal Marsden Hospital, London · Paul Lorigan, University of Manchester, Manchester, United Kingdom · Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris · Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France · Benjamin Brady, Cabrini Health, Melbourne, Australia · Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium · Henrik Schmidt, Århus University, Åarhus, Denmark · Jessica C. Hassel, University Hospital Heidelberg, Heidelberg · Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude · Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver · Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada · Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL · and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia. · Royal North Shore and Mater Hospitals, Sydney, Australia. · Vanderbilt University Medical Center, Nashville, USA. · Princess Alexandra Hospital, Greenslopes Hospital and University of Queensland, Brisbane, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, Australia. · The University of Texas MD Anderson Cancer Center, Houston, USA. · Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medical Oncology, University of California San Francisco, San Francisco, USA. · Department of Medical Oncology, Moffitt Cancer Centre, Tampa, USA. · Department of Medical Oncology, Olivia Newton-John Cancer Centre & Cancer Research Institute, Austin Health, Melbourne, Australia. · Department of Dermatology, Heidelberg University, Heidelberg, Germany. · Massachusetts General Hospital Cancer Center, Boston, USA. · Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, USA. · Pubmed 27687304
2016
  • a Department of Medicine , Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center , Nashville , TN , USA. · b Department of Pharmacology , Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center , Nashville , TN , USA. · Pubmed 27148822
  • Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Pubmed 26743513
  • New York University Langone Medical Center, New York, NY, USA; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Massachusetts General Hospital, Boston, MA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Virginia School of Medicine, Charlottesville, VA, USA. · Indiana University Simon Cancer Center, Indianapolis, IN, USA. · University of Pennsylvania, Philadelphia, PA, USA. · Lehigh Valley Health Network, Allentown, PA, USA. · Indiana University Simon Cancer Center, Indianapolis, IN, USA; University of Michigan, Ann Arbor, MI, USA. · Beth Israel Deaconess Medical Center, Boston, MA, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27269740
  • Georgina V. Long, Melanoma Institute Australia · The University of Sydney · Richard F. Kefford, Melanoma Institute Australia · The University of Sydney · Macquarie University, Sydney · Westmead Hospital, Westmead · Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia · Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL · Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology · Kevin B. Kim, California Pacific Medical Center · Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA · Rene Gonzalez, Karl Lewis, University of Colorado · Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO · Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN · Lynn Schuchter, University of Pennsylvania Abramson Cancer Center · Nageatte Ibrahim, Elizabeth Cunningham, Merck · Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA · Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE · and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, TN, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA. · Division of Surgical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Pubmed 26176864
  • From the Departments of Medicine (D.B.J., J.M.B., M.H., I.P., M.R.A., T.L.B., J.R.B., D.A.S., E.J.P., M.A.P., D.M.R., J.A.S., J.J.M.), Cancer Biology (J.M.B., J.J.M.), Pathology, Microbiology, and Immunology (M.L.C., L.C.-O., R.D.H.), Biostatistics (Y.X.), Pharmacology (D.M.R.), and Biomedical Informatics (Y.X., D.M.R.), the Cardio-oncology Program (D.A.S., J.J.M.), the Breast Cancer Research Program (J.M.B.), and the Center for Quantitative Sciences (Y.X.), Vanderbilt University Medical Center, Nashville · the Department of Medicine (S.C.) and the Division of Neuroimmunology (S.C., I.J.K.), Beth Israel Deaconess Medical Center, the Departments of Medicine (B.A.O., C.E.S., J.G.S.) and Pathology (A.H.L.), Brigham and Women's Hospital, the Department of Genetics, Harvard Medical School (J.G., C.E.S., J.G.S.) - all in Boston · Howard Hughes Medical Institute, Chevy Chase, MD (C.E.S.) · Bristol-Myers Squibb, New York (N.K., G.P., D.S.R., J.S.D.) · Neon Therapeutics, Cambridge, MA (R.P.D.) · and the Departments of Pathology (J.M.T., R.A.A.), Dermatology (J.M.T.), and Oncology (L.A.D.), Johns Hopkins University, Baltimore. · Pubmed 27806233
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York. · Moffitt Cancer Center, Tampa, Florida. · Spanish Melanoma Multidisciplinary Group, Barcelona, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Columbia University Medical Center, New York, New York. · Johansson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. · Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York. · Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 27533448
  • Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida. · Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida. · Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 27197063
  • Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA. · School of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Pubmed 27089234
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. · University of the Sciences, Philadelphia, Pennsylvania 19104, USA. · Department of Dermatology, University of Zurich, Zurich CH-8006, Switzerland. · The National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. · Department of Dermatology and Pathology, Yale University, New Haven, Connecticut 06511, USA. · Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston 02114, Massachusetts, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Department of Medical Oncology, City of Hope Medical Center, Duarte, California 91010, USA. · Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California 90095, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead 2145, Australia. · Melanoma Institute Australia and The University of Sydney, Sydney 2000, Australia. · Department of Medicine, Vanderbilt University Medical Center, Nashville Tennessee 37232, USA. · Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg 45127, Germany. · Pubmed 27042933
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26997480
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN. · Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. · Laboratoire d'Hématologie, Pôle Cellules et Tissus, CHU, INSERM UMR 917, Rennes, France. · Pubmed 26966176
  • Department of Medicine, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Pathology, Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Department of Cancer Biology, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, 37232 Tennessee, USA. · Department of Medicine, Massachusetts General Hospital, Boston, 02114 Massachusetts, USA. · Department of Surgical Oncology, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Biostatistics, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Pubmed 26822383
  • Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN (AEV, CAJ, JY, JSP, DR, AR) · Department of Cancer Biology (AEV, AJ, JY, SCC, JSP, DR, AR), Center for Quantitative Sciences (SCC), Division of Cancer Biostatistics, Department of Biostatistics (GDA, YS), Division of Hematology/Oncology, Department of Medicine (JAS), Vanderbilt University Medical Center, Nashville, TN · HudsonAlpha Institute for Biotechnology, Huntsville, Alabama (NP, SEL) · Division of Surgical Oncology, Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN (MK) · Translational Medicine, Takeda Pharmaceuticals International Co, Cambridge, MA (JAE). · Pubmed 26719346
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia5Department of Medicine, University of Sydney, Sydney, New South Wales, Australia. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, University of Sydney, Sydney, New South Wales, Australia8Department of Medicine, Melanoma Institute Australia, Sydney, New South Wales, Australia. · medical student at School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick. · Department of Medicine, Heidelberg University Hospital, Heidelberg, Germany. · Department of Medicine, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia8Department of Medicine, Melanoma Institute Australia, Sydney, New South Wales, Australia. · Department of Surgery, Rutgers Cancer Institute of New Jersey, New Brunswick. · Department of Medicine, Loyola University Medical Center, Maywood, Illinois. · Pubmed 26633184
  • Department of Molecular Oncology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Proteomics, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Biostatistics and Bioinformatics, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Cutaneous Oncology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. · Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 26073081
2015
  • Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee2Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 26181188
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Hematology-Oncology, Vanderbilt University, Nashville, Tennessee. · Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Hematology-Oncology, Beth Israel-Deaconess Medical Center, Boston, Massachusetts. · Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts. · Hematology-Oncology, Washington University in St. Louis, St. Louis, Missouri. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26264378
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • Yale Cancer Center, New Haven, Connecticut. Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Yale Cancer Center, New Haven, Connecticut. Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Translational Genomics Research Institute, Phoenix, Arizona. · Biometrics Research Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland. · University of Michigan Comprehensive Cancer Center (UMCCC), Ann Arbor, Michigan. · Mayo Clinic, Rochester, Minnesota. · Mayo Clinic, Scottsdale, Arizona. · Mayo Clinic, Jacksonville, Florida. · Charles A. Sammons Cancer Center/Baylor University Medical Center, Dallas, Texas. · Vanderbilt University, Nashville, Tennessee. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Columbia University, New York, New York. · Pubmed 26063764
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Abramson Cancer Center and the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Pubmed 25980594
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 25649350
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26359985
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 26225893
  • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Cell Biology, Columbia University, New York, New York. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · University of Texas, MD Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Genentech, Inc., South San Francisco, San Francisco, California. · Peter MacCallum Cancer Centre and University of Melbourne, Australia, Melbourne, Victoria, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26202952
  • Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Translational Medicine, Takeda Pharmaceuticals International C, Cambridge, Massachusetts. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Surgical Oncology, Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 26152738
  • Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine/Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Surgery, Division of Surgical Oncology and Endocrine Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Currently an employee of Roche Pharma Research and Early Development, Basel, Switzerland. · Pubmed 26084293
  • Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN. · Memorial Sloan-Kettering Cancer Center, New York, NY. · Vanderbilt University School of Medicine Center for Quantitative Science, Nashville, TN. · Massachusetts General Hospital, Boston, MA. · Columbia University Medical Center, New York, NY. · Pubmed 25736262
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Oncology, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. · Discovery Oncology, Merck Research Laboratories, Boston, MA 02115, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Radiological Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 25600339
  • Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Pubmed 25537510
  • Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Meharry Medical College, Nashville, Tennessee. · Flow Cytometry Shared Resource, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Cancer Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. · Takeda Pharmaceuticals International Co., Cambridge, Massachusetts. · Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 25398437
  • Vanderbilt University Medical Center, Nashville, TN · H. Lee Moffitt Cancer Center, Tampa, FL. · Vanderbilt University Medical Center, Nashville, TN. · Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 24778401
2014
  • Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; and · Departments of Molecular Oncology and Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; and. · Pubmed 24895460
  • Lawrence E. Flaherty, Wayne State University, Detroit · Bruce G. Redman, University of Michigan, Ann Arbor, MI · Megan Othus, James Moon, Southwest Oncology Group Statistical Center · John A. Thompson, Seattle Cancer Care Alliance, Seattle, WA · Michael B. Atkins, Georgetown University Hospital, Washington DC · Ralph J. Tuthill, Cleveland Clinic Foundation, Cleveland, OH · John T. Vetto, Oregon Health & Science University/Knight Cancer Institute, Portland, OR · Frank G. Haluska, Tufts-New England Medical Center, Boston, MA · Alberto S. Pappo, Texas Children's Cancer Center, Houston, TX · Jeffrey A. Sosman, Vanderbilt University School of Medicine Nashville, TN · Antoni Ribas, University of California Los Angeles, Los Angeles, CA · John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL. · Pubmed 25332243
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center · Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN · Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA · Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL · Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX · Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales · Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia · Omid Hamid, Angeles Clinic and Research Institute, Los Angeles · Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA · Lynn Schuchter, University of Pennsylvania Abramson Cancer Center · Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA · William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD · Robert R. McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO · and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • Division of Surgical Oncology, The Ohio State University, Columbus, Ohio. · SWOG Statistical Center, Seattle, Washington. · Vanderbilt University, Nashville, Tennessee. · Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Cleveland Clinic Foundation, Cleveland, Ohio. · Division of Surgical Oncology, The Ohio State University, Columbus, Ohio. · Seattle Cancer Care Alliance, Seattle, Washington. · Los Angeles County Department of Health Services, University of Southern California, Los Angeles, California. · University of California Los Angeles, Los Angeles, California. · H. Lee Moffitt Cancer Center, Tampa, Florida. · Pubmed 24994597
  • Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York. · Vanderbilt University Medical Center, Department of Hematology-Oncology, Nashville, Tennessee. · Mayo Clinic, Rochester, Minnesota. · University of Iowa Hospital and Clinics, Iowa City. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · H. Lee Moffitt Cancer Center, Tampa, Florida. · Washington University, St Louis, Missouri. · University of Chicago, Chicago, Illinois. · Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · University of Michigan, Ann Arbor. · Metro Minnesota Community Clinical Oncology Program, St Louis Park. · University of Wisconsin, Madison. · Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania. · University of Colorado, Aurora. · Investigational Drug Branch, National Cancer Institute, Rockville, Maryland. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24938562
  • Suzanne L. Topalian, William H. Sharfman, Julie R. Brahmer, Evan J. Lipson, Janis M. Taube, and Drew M. Pardoll, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Mario Sznol and Harriet M. Kluger, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · David F. McDermott, Beth Israel Deaconess Medical Center · Donald P. Lawrence, Massachusetts General Hospital Cancer Center · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Richard D. Carvajal, Memorial Sloan-Kettering Cancer Center, New York, NY · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · John D. Powderly, Carolina BioOncology Institute, Huntersville, NC · Philip D. Leming, The Christ Hospital Cancer Center, Cincinnati, OH · Igor Puzanov and Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · David C. Smith, University of Michigan, Ann Arbor, MI · and Jon M. Wigginton, Georgia D. Kollia, and Ashok Gupta, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 24590637
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA · Pubmed 24797823
  • Authors' Affiliations: Department of Biomedical Informatics; · Authors' Affiliations: Department of Biomedical Informatics; Center for Quantitative Sciences; · Department of Cancer Biology; · Department of Cancer Biology; Vanderbilt-Ingram Cancer Center; and. · Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center; and Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center; and Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee · Authors' Affiliations: Department of Biomedical Informatics; Center for Quantitative Sciences; Department of Cancer Biology; Vanderbilt-Ingram Cancer Center; and · Pubmed 24755198
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Foundation Medicine, Inc., Cambridge, Massachusetts. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York. · Foundation Medicine, Inc., Cambridge, Massachusetts. · Department of Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 25512636
2013
  • Vanderbilt University Medical Center. · Mayo Clinic Jacksonville. · Pubmed 24490176
2012
  • Vanderbilt-Ingram Cancer Center, Nashville, TN 37232-6307, USA. · Pubmed 22356324
2011
  • Vanderbilt University School of Medicine, Department of Medicine, Nashville, Tennessee, USA. · Pubmed 21455999
2009
  • Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN 37232, USA. · Pubmed 19679016
2008
  • Vanderbilt-Ingram Cancer Center Vanderbilt, University Medical Center, Section of Hematology/Oncology, 777 Preston Research Bldg, Nashville, TN 37232-6307, USA. · Pubmed 18467720
2017
  • *Vanderbilt University Medical Center, Nashville, TN †Beth Israel Deaconess Medical Center ‡Dana-Farber Cancer Institute §Massachusetts General Hospital, Boston, MA. · Pubmed 27846054
2015
  • Vanderbilt University Medical Center, Department of Medicine , 777 PRB, 2220 Pierce Ave, Nashville, TN 37232 , USA +1 615 322 8131 ; +1 615 343 7602 ; · Pubmed 25812921
  • Department of Medicine, School of Medicine, Department of Radiology, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Departments of Medicine and Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Columbia University Medical Center, New York, New York, USA · Department of Medicine, School of Medicine, Department of Radiology, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Departments of Medicine and Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Columbia University Medical Center, New York, New York, USA. · Pubmed 25964307
2014
  • Authors' Affiliations: Departments of Cancer Biology, Medicine, Biomedical Informatics, and Pathology, Microbiology, and Immunology; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 24599935
  • From the Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 24812130
2013
  • Vanderbilt Ingram Cancer Center, 2220 Pierce Ave. 777 Preston Research Building, Nashville, TN 37232-6307, USA. · Pubmed 23420410
  • Vanderbilt-Ingram Cancer Center, 777 Preston Research Building, Nashville, TN 37232-6307, USA. · Pubmed 23569304
  • Authors' Affiliations: Departments of Cancer Biology, Biochemistry, Vanderbilt-Ingram Cancer Center; Departments of Pathology, Microbiology, and Immunology, Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee; Foundation Medicine, Inc., Cambridge, Massachusetts; and Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York. · Pubmed 24345920
  • Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, USA. · Pubmed 23180582
2012
  • Vanderbilt-Ingram Cancer Center, Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. · Pubmed 22798288
  • Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America. · Pubmed 22536370
  • Department of Veterans Affairs, Vanderbilt-Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. · Pubmed 22351689
2010
  • Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232, USA. · Pubmed 20425073
  • Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37027, USA. · Pubmed 20028756
Probable:    Northwestern University   Contact    
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Montefiore Medical Center, Albert Einstein Cancer Center, Bronx, NY, USA. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · Mayo Clinic, Rochester, MN, USA. · University of Iowa Carver College of Medicine, Iowa City, IA, USA. · Princess Margaret Hospital University Health Network, Toronto, ON, Canada. · Penn Medicine, Philadelphia, PA, USA. · University of Chicago, Chicago, IL, USA. · Mount Sinai Medical Center, Miami Beach, FL, USA. · University of Michigan, Ann Arbor, MI, USA. · Minnesota Oncology, Woodbury, MN, USA. · Univeristy of Wisconsin School of Medicine and Public Health, Madison, WI, USA. · Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA. · University of Colorado - Denver, Denver, CO, USA. · Columbia University Medical Center, New York, NY, USA. · Pubmed 27921276
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, University of Chicago, Chicago, Illinois. · Department of Medicine, Mayo Clinic Florida, Jacksonville, Florida. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 28396509
  • Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic, Scottsdale, Arizona 85259, USA. · University of Arizona, College of Pharmacy, Tucson, Arizona 85721, USA. · Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA. · Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea. · Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA. · Pubmed 28373299
2017
  • From the Division of Hematology/Oncology, Northwestern Feinberg School of Medicine, Chicago, IL. · Pubmed 28114255
Probable:    Miscellaneous institutions in Chicago      
2017
  • a Internal Medicine Department , Chicago , IL , USA. · b Division of Hematology Oncology , Chicago , IL , USA. · Pubmed 28562096
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 112 total) written by Jeffrey Alan Sosman about Melanoma:

  • High response rate to PD-1 blockade in desmoplastic melanomas. 2018
  • Emerging growth factor receptor antagonists for the treatment of advanced melanoma. 2017
  • Novel Targeted Therapies for Metastatic Melanoma. 2017
  • Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. 2017
  • A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status. 2017
  • Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697). 2017
  • Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma. 2017
  • A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors. 2017
  • Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study. 2017
  • Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation. 2017
Show List of Full Article Records
Google Searches

Learn more about Jeffrey Alan Sosman using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Vanderbilt University
Northwestern University
Miscellaneous institutions in Chicago
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Vanderbilt University
2018
  • University of California Los Angeles, Los Angeles, California, USA. · Moffitt Cancer Center and University of South Florida, Tampa, Florida, USA. · The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA. · University of California San Francisco, San Francisco, California, USA. · Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Weill Cornell Medical College, New York, New York, USA. · Georgetown Lombardi Cancer Center, Washington DC, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, California, USA. · Mayo Clinic, Jacksonville, Florida, USA. · The University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Pubmed 29320474
2017
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Center for Cancer Precision Medicine/Dana-Farber Cancer Institute and the Broad Institute, Boston, Massachusetts. · Broad Institute of MIT and Harvard, Cambridge, Massachusetts. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. · Dana Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · California Pacific Medical Center Research Institute, San Francisco, California. · Vanderbilt-Ingram Cancer Center, Vanderbilt, Tennessee. · University Hospital, Zurich, Switzerland. · Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Novartis Pharma AG, Basel, Switzerland. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia. · Pubmed 28719152
  • Sanjiv S. Agarwala, Saint Luke's University Hospital, Easton · Uma N. Rao, Ahmad A. Tarhini, Terry L. Evans, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Sandra J. Lee, and Waiki Yip, Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA · Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD · Douglas S. Reintgen, Lakeland Regional Cancer Center, Lakeland · Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL · Joanna M. Brell, MetroHealth Medical Center, Cleveland · William E. Carson, The Ohio State University Comprehensive Cancer Center, Columbus, OH · Mark R. Albertini, University of Wisconsin Hospital, Madison, WI · Michael B. Atkins, Georgetown Medical Center, Washington, DC · Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS · Robert M. Conry, University of Alabama at Birmingham, Birmingham, AL · Jeffrey A. Sosman, Vanderbilt University, Nashville · Alberto S. Pappo, Saint Jude Children's Research Hospital Oncology, Memphis, TN · Lawrence E. Flaherty, Wayne State University/Karmanos Cancer Institute, Detroit, MI · Michael G. Smylie, Cross Cancer Institute, Edmonton, Canada · and Richard F. Kefford, Sydney West Area Health Service, Westmead, Australia. · Pubmed 28135150
  • Department of Oncology, Mayo Clinic, 200 First St, SW, Rochester, MN, 55905, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Yale University, New Haven, CT, USA. · University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · New York University Langone Medical Center, New York, NY, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · AstraZeneca Pharmaceuticals, Waltham, MA, USA. · Present address: Array BioPharma Inc., Boulder, CO, USA. · Pubmed 27650277
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · David Geffen School of Medicine, University of California, Los Angeles, California. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, California. · Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, California. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Pubmed 28864476
  • Genentech, Inc., South San Francisco, California. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia, and University of Melbourne, Parkville, Victoria, Australia. · Nantes University, Nantes, France. · The Royal Marsden NHS Foundation Trust, London, United Kingdom. · Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · HistoGeneX, Antwerp, Belgium. · Genentech, Inc., South San Francisco, California. · Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, California. · Pubmed 28536307
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · James Larkin, Royal Marsden Hospital, London · Paul Lorigan, University of Manchester, Manchester, United Kingdom · Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris · Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France · Benjamin Brady, Cabrini Health, Melbourne, Australia · Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium · Henrik Schmidt, Århus University, Åarhus, Denmark · Jessica C. Hassel, University Hospital Heidelberg, Heidelberg · Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude · Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver · Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada · Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL · and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia. · Royal North Shore and Mater Hospitals, Sydney, Australia. · Vanderbilt University Medical Center, Nashville, USA. · Princess Alexandra Hospital, Greenslopes Hospital and University of Queensland, Brisbane, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, Australia. · The University of Texas MD Anderson Cancer Center, Houston, USA. · Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medical Oncology, University of California San Francisco, San Francisco, USA. · Department of Medical Oncology, Moffitt Cancer Centre, Tampa, USA. · Department of Medical Oncology, Olivia Newton-John Cancer Centre & Cancer Research Institute, Austin Health, Melbourne, Australia. · Department of Dermatology, Heidelberg University, Heidelberg, Germany. · Massachusetts General Hospital Cancer Center, Boston, USA. · Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, USA. · Pubmed 27687304
2016
  • a Department of Medicine , Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center , Nashville , TN , USA. · b Department of Pharmacology , Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center , Nashville , TN , USA. · Pubmed 27148822
  • Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Pubmed 26743513
  • New York University Langone Medical Center, New York, NY, USA; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Massachusetts General Hospital, Boston, MA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Virginia School of Medicine, Charlottesville, VA, USA. · Indiana University Simon Cancer Center, Indianapolis, IN, USA. · University of Pennsylvania, Philadelphia, PA, USA. · Lehigh Valley Health Network, Allentown, PA, USA. · Indiana University Simon Cancer Center, Indianapolis, IN, USA; University of Michigan, Ann Arbor, MI, USA. · Beth Israel Deaconess Medical Center, Boston, MA, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27269740
  • Georgina V. Long, Melanoma Institute Australia · The University of Sydney · Richard F. Kefford, Melanoma Institute Australia · The University of Sydney · Macquarie University, Sydney · Westmead Hospital, Westmead · Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia · Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL · Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology · Kevin B. Kim, California Pacific Medical Center · Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA · Rene Gonzalez, Karl Lewis, University of Colorado · Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO · Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN · Lynn Schuchter, University of Pennsylvania Abramson Cancer Center · Nageatte Ibrahim, Elizabeth Cunningham, Merck · Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA · Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE · and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Sarah Cannon Research Institute and Tennessee Oncology PLLC, Nashville, TN, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA. · Division of Surgical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Pubmed 26176864
  • From the Departments of Medicine (D.B.J., J.M.B., M.H., I.P., M.R.A., T.L.B., J.R.B., D.A.S., E.J.P., M.A.P., D.M.R., J.A.S., J.J.M.), Cancer Biology (J.M.B., J.J.M.), Pathology, Microbiology, and Immunology (M.L.C., L.C.-O., R.D.H.), Biostatistics (Y.X.), Pharmacology (D.M.R.), and Biomedical Informatics (Y.X., D.M.R.), the Cardio-oncology Program (D.A.S., J.J.M.), the Breast Cancer Research Program (J.M.B.), and the Center for Quantitative Sciences (Y.X.), Vanderbilt University Medical Center, Nashville · the Department of Medicine (S.C.) and the Division of Neuroimmunology (S.C., I.J.K.), Beth Israel Deaconess Medical Center, the Departments of Medicine (B.A.O., C.E.S., J.G.S.) and Pathology (A.H.L.), Brigham and Women's Hospital, the Department of Genetics, Harvard Medical School (J.G., C.E.S., J.G.S.) - all in Boston · Howard Hughes Medical Institute, Chevy Chase, MD (C.E.S.) · Bristol-Myers Squibb, New York (N.K., G.P., D.S.R., J.S.D.) · Neon Therapeutics, Cambridge, MA (R.P.D.) · and the Departments of Pathology (J.M.T., R.A.A.), Dermatology (J.M.T.), and Oncology (L.A.D.), Johns Hopkins University, Baltimore. · Pubmed 27806233
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, New York. · Moffitt Cancer Center, Tampa, Florida. · Spanish Melanoma Multidisciplinary Group, Barcelona, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Columbia University Medical Center, New York, New York. · Johansson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. · Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York. · Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 27533448
  • Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida. · Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida. · Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 27197063
  • Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA. · School of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Pubmed 27089234
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. · University of the Sciences, Philadelphia, Pennsylvania 19104, USA. · Department of Dermatology, University of Zurich, Zurich CH-8006, Switzerland. · The National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. · Department of Dermatology and Pathology, Yale University, New Haven, Connecticut 06511, USA. · Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston 02114, Massachusetts, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Department of Medical Oncology, City of Hope Medical Center, Duarte, California 91010, USA. · Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California 90095, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead 2145, Australia. · Melanoma Institute Australia and The University of Sydney, Sydney 2000, Australia. · Department of Medicine, Vanderbilt University Medical Center, Nashville Tennessee 37232, USA. · Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg 45127, Germany. · Pubmed 27042933
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26997480
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN. · Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. · Laboratoire d'Hématologie, Pôle Cellules et Tissus, CHU, INSERM UMR 917, Rennes, France. · Pubmed 26966176
  • Department of Medicine, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Pathology, Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Department of Cancer Biology, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, 37232 Tennessee, USA. · Department of Medicine, Massachusetts General Hospital, Boston, 02114 Massachusetts, USA. · Department of Surgical Oncology, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Department of Biostatistics, Vanderbilt University, Nashville, 37232 Tennessee, USA. · Pubmed 26822383
  • Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN (AEV, CAJ, JY, JSP, DR, AR) · Department of Cancer Biology (AEV, AJ, JY, SCC, JSP, DR, AR), Center for Quantitative Sciences (SCC), Division of Cancer Biostatistics, Department of Biostatistics (GDA, YS), Division of Hematology/Oncology, Department of Medicine (JAS), Vanderbilt University Medical Center, Nashville, TN · HudsonAlpha Institute for Biotechnology, Huntsville, Alabama (NP, SEL) · Division of Surgical Oncology, Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN (MK) · Translational Medicine, Takeda Pharmaceuticals International Co, Cambridge, MA (JAE). · Pubmed 26719346
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia5Department of Medicine, University of Sydney, Sydney, New South Wales, Australia. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, University of Sydney, Sydney, New South Wales, Australia8Department of Medicine, Melanoma Institute Australia, Sydney, New South Wales, Australia. · medical student at School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick. · Department of Medicine, Heidelberg University Hospital, Heidelberg, Germany. · Department of Medicine, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia8Department of Medicine, Melanoma Institute Australia, Sydney, New South Wales, Australia. · Department of Surgery, Rutgers Cancer Institute of New Jersey, New Brunswick. · Department of Medicine, Loyola University Medical Center, Maywood, Illinois. · Pubmed 26633184
  • Department of Molecular Oncology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Proteomics, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Biostatistics and Bioinformatics, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Cutaneous Oncology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. · Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 26073081
2015
  • Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee2Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 26181188
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Hematology-Oncology, Vanderbilt University, Nashville, Tennessee. · Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Hematology-Oncology, Beth Israel-Deaconess Medical Center, Boston, Massachusetts. · Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts. · Hematology-Oncology, Washington University in St. Louis, St. Louis, Missouri. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26264378
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • Yale Cancer Center, New Haven, Connecticut. Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Yale Cancer Center, New Haven, Connecticut. Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Translational Genomics Research Institute, Phoenix, Arizona. · Biometrics Research Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland. · University of Michigan Comprehensive Cancer Center (UMCCC), Ann Arbor, Michigan. · Mayo Clinic, Rochester, Minnesota. · Mayo Clinic, Scottsdale, Arizona. · Mayo Clinic, Jacksonville, Florida. · Charles A. Sammons Cancer Center/Baylor University Medical Center, Dallas, Texas. · Vanderbilt University, Nashville, Tennessee. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Columbia University, New York, New York. · Pubmed 26063764
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Abramson Cancer Center and the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Pubmed 25980594
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 25649350
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26359985
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 26225893
  • Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Department of Pathology and Cell Biology, Columbia University, New York, New York. · Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia. Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Melanoma Institute Australia and The University of Sydney, New South Wales, Australia. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · University of Texas, MD Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Genentech, Inc., South San Francisco, San Francisco, California. · Peter MacCallum Cancer Centre and University of Melbourne, Australia, Melbourne, Victoria, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26202952
  • Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Translational Medicine, Takeda Pharmaceuticals International C, Cambridge, Massachusetts. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Surgical Oncology, Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 26152738
  • Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine/Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Surgery, Division of Surgical Oncology and Endocrine Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Currently an employee of Roche Pharma Research and Early Development, Basel, Switzerland. · Pubmed 26084293
  • Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN. · Memorial Sloan-Kettering Cancer Center, New York, NY. · Vanderbilt University School of Medicine Center for Quantitative Science, Nashville, TN. · Massachusetts General Hospital, Boston, MA. · Columbia University Medical Center, New York, NY. · Pubmed 25736262
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Oncology, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. · Discovery Oncology, Merck Research Laboratories, Boston, MA 02115, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Radiological Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 25600339
  • Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Pubmed 25537510
  • Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Meharry Medical College, Nashville, Tennessee. · Flow Cytometry Shared Resource, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Cancer Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. · Takeda Pharmaceuticals International Co., Cambridge, Massachusetts. · Tennessee Valley Healthcare System, Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 25398437
  • Vanderbilt University Medical Center, Nashville, TN · H. Lee Moffitt Cancer Center, Tampa, FL. · Vanderbilt University Medical Center, Nashville, TN. · Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 24778401
2014
  • Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; and · Departments of Molecular Oncology and Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida. · Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; and. · Pubmed 24895460
  • Lawrence E. Flaherty, Wayne State University, Detroit · Bruce G. Redman, University of Michigan, Ann Arbor, MI · Megan Othus, James Moon, Southwest Oncology Group Statistical Center · John A. Thompson, Seattle Cancer Care Alliance, Seattle, WA · Michael B. Atkins, Georgetown University Hospital, Washington DC · Ralph J. Tuthill, Cleveland Clinic Foundation, Cleveland, OH · John T. Vetto, Oregon Health & Science University/Knight Cancer Institute, Portland, OR · Frank G. Haluska, Tufts-New England Medical Center, Boston, MA · Alberto S. Pappo, Texas Children's Cancer Center, Houston, TX · Jeffrey A. Sosman, Vanderbilt University School of Medicine Nashville, TN · Antoni Ribas, University of California Los Angeles, Los Angeles, CA · John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL. · Pubmed 25332243
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center · Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN · Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA · Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL · Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX · Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales · Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia · Omid Hamid, Angeles Clinic and Research Institute, Los Angeles · Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA · Lynn Schuchter, University of Pennsylvania Abramson Cancer Center · Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA · William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD · Robert R. McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO · and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • Division of Surgical Oncology, The Ohio State University, Columbus, Ohio. · SWOG Statistical Center, Seattle, Washington. · Vanderbilt University, Nashville, Tennessee. · Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Cleveland Clinic Foundation, Cleveland, Ohio. · Division of Surgical Oncology, The Ohio State University, Columbus, Ohio. · Seattle Cancer Care Alliance, Seattle, Washington. · Los Angeles County Department of Health Services, University of Southern California, Los Angeles, California. · University of California Los Angeles, Los Angeles, California. · H. Lee Moffitt Cancer Center, Tampa, Florida. · Pubmed 24994597
  • Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York. · Vanderbilt University Medical Center, Department of Hematology-Oncology, Nashville, Tennessee. · Mayo Clinic, Rochester, Minnesota. · University of Iowa Hospital and Clinics, Iowa City. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · H. Lee Moffitt Cancer Center, Tampa, Florida. · Washington University, St Louis, Missouri. · University of Chicago, Chicago, Illinois. · Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · University of Michigan, Ann Arbor. · Metro Minnesota Community Clinical Oncology Program, St Louis Park. · University of Wisconsin, Madison. · Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania. · University of Colorado, Aurora. · Investigational Drug Branch, National Cancer Institute, Rockville, Maryland. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24938562
  • Suzanne L. Topalian, William H. Sharfman, Julie R. Brahmer, Evan J. Lipson, Janis M. Taube, and Drew M. Pardoll, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Mario Sznol and Harriet M. Kluger, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · David F. McDermott, Beth Israel Deaconess Medical Center · Donald P. Lawrence, Massachusetts General Hospital Cancer Center · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Richard D. Carvajal, Memorial Sloan-Kettering Cancer Center, New York, NY · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · John D. Powderly, Carolina BioOncology Institute, Huntersville, NC · Philip D. Leming, The Christ Hospital Cancer Center, Cincinnati, OH · Igor Puzanov and Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · David C. Smith, University of Michigan, Ann Arbor, MI · and Jon M. Wigginton, Georgia D. Kollia, and Ashok Gupta, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 24590637
  • Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. Electronic address: · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave Roussy, Paris, France. · Royal Marsden Hospital, London, UK. · The Netherlands Cancer Institute, Amsterdam, Netherlands. · University of Zurich, Zurich, Switzerland. · Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA, USA. · Princess Margaret Hospital and University Health Network, Toronto, ON, Canada. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · The University of Tübingen, Tübingen, Germany. · Istituto Europeo di Oncologia, Milan, Italy. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · University of Manchester, Manchester, UK. · APHP Oncodermatology, Hôpital Saint Louis University, Paris, France. · Saint André Hospital, Bordeaux, France. · University Hospital Essen, Essen, Germany. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Gustave-Roussy Cancer Center and University Paris-Sud, Villejuif/Paris Sud, France. · Nantes University Hospital, Nantes, France. · Vanderbilt University School of Medicine, Nashville, TN, USA. · Massachusetts General Hospital, Boston, MA, USA. · Genentech Inc, San Francisco, CA, USA. · Roche Molecular Systems Inc, Pleasanton, CA, USA. · F Hoffmann-La Roche, Basel, Switzerland. · University of Kiel, Kiel, Germany. · Pubmed 24508103
  • Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA · Pubmed 24797823
  • Authors' Affiliations: Department of Biomedical Informatics; · Authors' Affiliations: Department of Biomedical Informatics; Center for Quantitative Sciences; · Department of Cancer Biology; · Department of Cancer Biology; Vanderbilt-Ingram Cancer Center; and. · Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center; and Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center; and Department of Medicine/Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee · Authors' Affiliations: Department of Biomedical Informatics; Center for Quantitative Sciences; Department of Cancer Biology; Vanderbilt-Ingram Cancer Center; and · Pubmed 24755198
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Foundation Medicine, Inc., Cambridge, Massachusetts. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York. · Foundation Medicine, Inc., Cambridge, Massachusetts. · Department of Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 25512636
2013
  • Vanderbilt University Medical Center. · Mayo Clinic Jacksonville. · Pubmed 24490176
2012
  • Vanderbilt-Ingram Cancer Center, Nashville, TN 37232-6307, USA. · Pubmed 22356324
2011
  • Vanderbilt University School of Medicine, Department of Medicine, Nashville, Tennessee, USA. · Pubmed 21455999
2009
  • Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN 37232, USA. · Pubmed 19679016
2008
  • Vanderbilt-Ingram Cancer Center Vanderbilt, University Medical Center, Section of Hematology/Oncology, 777 Preston Research Bldg, Nashville, TN 37232-6307, USA. · Pubmed 18467720
2017
  • *Vanderbilt University Medical Center, Nashville, TN †Beth Israel Deaconess Medical Center ‡Dana-Farber Cancer Institute §Massachusetts General Hospital, Boston, MA. · Pubmed 27846054
2015
  • Vanderbilt University Medical Center, Department of Medicine , 777 PRB, 2220 Pierce Ave, Nashville, TN 37232 , USA +1 615 322 8131 ; +1 615 343 7602 ; · Pubmed 25812921
  • Department of Medicine, School of Medicine, Department of Radiology, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Departments of Medicine and Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Columbia University Medical Center, New York, New York, USA · Department of Medicine, School of Medicine, Department of Radiology, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Departments of Medicine and Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Columbia University Medical Center, New York, New York, USA. · Pubmed 25964307
2014
  • Authors' Affiliations: Departments of Cancer Biology, Medicine, Biomedical Informatics, and Pathology, Microbiology, and Immunology; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 24599935
  • From the Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 24812130
2013
  • Vanderbilt Ingram Cancer Center, 2220 Pierce Ave. 777 Preston Research Building, Nashville, TN 37232-6307, USA. · Pubmed 23420410
  • Vanderbilt-Ingram Cancer Center, 777 Preston Research Building, Nashville, TN 37232-6307, USA. · Pubmed 23569304
  • Authors' Affiliations: Departments of Cancer Biology, Biochemistry, Vanderbilt-Ingram Cancer Center; Departments of Pathology, Microbiology, and Immunology, Medicine, Division of Hematology-Oncology, Vanderbilt University School of Medicine; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee; Foundation Medicine, Inc., Cambridge, Massachusetts; and Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York. · Pubmed 24345920
  • Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, USA. · Pubmed 23180582
2012
  • Vanderbilt-Ingram Cancer Center, Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. · Pubmed 22798288
  • Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America. · Pubmed 22536370
  • Department of Veterans Affairs, Vanderbilt-Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. · Pubmed 22351689
2010
  • Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232, USA. · Pubmed 20425073
  • Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37027, USA. · Pubmed 20028756
Northwestern University
2017
  • From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.) · Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · University of Colorado, Denver (R.G.) · Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.) · Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France · Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.) · University of Michigan, Ann Arbor (C.D.L.) · the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom · the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.) · Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada · Universitäts Spital, Zurich, Switzerland (R.D.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia · Netherlands Cancer Institute, Amsterdam (J.H.) · University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.) · General University Hospital Gregorio Marañón, Madrid (I.M.-R.) · Northwestern University, Chicago (J.S.) · Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.) · and the Dana-Farber Cancer Institute, Boston (F.S.H.). · Pubmed 28889792
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA. · Montefiore Medical Center, Albert Einstein Cancer Center, Bronx, NY, USA. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · Mayo Clinic, Rochester, MN, USA. · University of Iowa Carver College of Medicine, Iowa City, IA, USA. · Princess Margaret Hospital University Health Network, Toronto, ON, Canada. · Penn Medicine, Philadelphia, PA, USA. · University of Chicago, Chicago, IL, USA. · Mount Sinai Medical Center, Miami Beach, FL, USA. · University of Michigan, Ann Arbor, MI, USA. · Minnesota Oncology, Woodbury, MN, USA. · Univeristy of Wisconsin School of Medicine and Public Health, Madison, WI, USA. · Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA. · University of Colorado - Denver, Denver, CO, USA. · Columbia University Medical Center, New York, NY, USA. · Pubmed 27921276
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medicine, Institut Gustave Roussy and Paris Sud University, Paris, France. · Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medicine, Hematology and Oncology, Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, USA. · Division of Medical Oncology and Hematology, Princess Margaret Hospital and University Health Network, Toronto, Canada. · The Angeles Clinic and Research Institute, Melanoma Therapeutics, Los Angeles, USA. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples. · Melanoma and Sarcoma, Istituto Europeo di Oncologia, Milan, Italy. · Department of Medical Oncology, University of Manchester, Manchester, UK. · Department of Dermatology, University of Zurich, Zurich, Switzerland. · Department of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Biostatistics in Product Development, Biometrics. · Clinical Department. · Product Development, Oncology, Genentech Inc., South San Francisco, USA. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne. · Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 28961848
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, University of Chicago, Chicago, Illinois. · Department of Medicine, Mayo Clinic Florida, Jacksonville, Florida. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 28396509
  • Translational Genomics Research Institute, Phoenix, Arizona 85004, USA. · Mayo Clinic, Scottsdale, Arizona 85259, USA. · University of Arizona, College of Pharmacy, Tucson, Arizona 85721, USA. · Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA. · Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea. · Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA. · Pubmed 28373299
2017
  • From the Division of Hematology/Oncology, Northwestern Feinberg School of Medicine, Chicago, IL. · Pubmed 28114255
Miscellaneous institutions in Chicago
2017
  • a Internal Medicine Department , Chicago , IL , USA. · b Division of Hematology Oncology , Chicago , IL , USA. · Pubmed 28562096
Unspecified
2014
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
24 Other Locations Show
Yearly article counts 11518201491331135
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.